•Whipple Surgery - During this procedure, surgeons remove the head of the pancreas, most of the duodenum (a part of the small intestine), a portion of the bile duct, the gallbladder, and associated lymph nodes. In some cases, the entire duodenum and a portion of the stomach must be removed. In these instances, surgeons reconstruct the digestive tract. Surgeons at Johns Hopkins honed the procedure, drastically reducing the mortality rate associated with the surgery.
•Distal Pancreatectomy - Surgeons remove tumors of the body and the tail of pancreas and leave the head of the pancreas intact.
•Total Pancreatectomy - This procedure is the least common of all of the surgeries and is used when tumors extend throughout the pancreas. In a total pancreatectomy, surgeons remove the entire pancreas and the spleen, gallbladder, common bile duct, and portions of the small intestine and stomach.
•Minimally-Invasive Pancreas Removal - Offered at only a select group of cancer centers like Johns Hopkins, this procedure can reduce blood loss, risk of infection and speed recovery. Eligibility depends on the tumor’s location, size and other medical factors.
•Palliative Surgical Procedures - These operations, such as a biliary and gastric bypass (double bypass) or a celiac nerve block, are performed to improve a patient's quality of life by reducing disease symptoms and pain.
Chemotherapy and radiation can also be employed - usually in combination with surgery - to cure the cancer (in early-stage diagnoses) or to prolong life:
•Chemotherapy - The leading chemotherapy agent is a drug called gemcitabine or Gemzar, and combined with a drug called taxol, also known as Abraxane, has shown increases in survival length.
•Radiation - Employing multiple beams of radiation, treatment can be very focused on the tumor, while limiting exposure to normal tissue. Stereotactic radiation therapy provides high doses of radiation over a shorter period of time than traditional radiation.
A pancreatic cancer vaccine, developed at Johns Hopkins Kimmel Cancer Center, is being tested with promising results, showing a modest, yet real improvement in survival time.